
 Delta-ALA urine test 
 
 
 
 To use the sharing features on this page, please enable JavaScript. 
 Delta-ALA is a protein (amino acid) produced by the liver. A test can be done to measure the amount of this substance in the urine. How the Test is Performed 
 
 After you provide a urine sample, it is tested in the lab. This is called a random urine sample. If needed, your health care provider may ask you to  collect your urine at home over 24 hours . This is called a 24-hour urine sample. Your provider will tell you how to do this. Follow instructions exactly so that the results are accurate. How to Prepare for the Test 
 
 Your health care provider may tell you to temporarily stop taking any medicines that can affect test results. Be sure to tell your provider about all the medicines you take. These include: Penicillin (an antibiotic) Barbiturates (medicnes to treat anxiety) Birth control pills Griseofulvin (medicine to treat fungal infections) How the Test will Feel 
 
 The test involves only normal urination. There is no discomfort. Why the Test is Performed 
 
 This test looks for an increased level of delta-ALA. It may be used to help diagnose a condition called  porphyria . Normal Results 
 
 In general, the normal range is less than 6 mg for a random urine sample. The normal range is 0 to 7 mg for a 24 hour sample. Normal value ranges may vary slightly from one lab to another. Some labs use different measurements or test different samples. Talk to your provider about the meaning of your specific test results. What Abnormal Results Mean 
 
 An increased level of urinary delta-ALA may indicate: Lead poisoning Porphyria (several types)  A decreased level may occur with chronic (long-term)  liver disease . Risks 
 
 There are no risks. Alternative Names 
 
 Delta-aminolevulinic acid Images 
 
 
 Urine sample 
 References 
 
 Fuller SJ, Wiley JS. Heme biosynthesis and its disorders. In: Hoffman R, Benz EJ Jr, Silberstein LE, Heslop HE, Weitz JI, Anastisi J, eds.  Hematology: Basic Principles and Practice.  6th ed. Philadelphia, PA: Elsevier Saunders; 2013:chap 36. Read More 
 
 Liver disease 
 
 Review Date 1/27/2015 
 
 
 Updated by: Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital, Boston, MA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.   
 Related MedlinePlus Health Topics 
 
 Lead Poisoning 
 Porphyria 
 Browse the Encyclopedia